Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): A randomized controlled trial |
| |
Authors: | Jerome Ateudjieu Beat Stoll Georges Nguefack-Tsague Christoph Tchangou Blaise Genton |
| |
Affiliation: | 1. Department of Biomedical Sciences, Faculty of Sciences, University of Dschang, Cameroon;2. Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland;3. Clinical Research Unit, Division of Health Operations Research, Ministry of Public Health, Cameroon;4. Institute of Social and Preventive Medicine, Faculty of Medicine, University of Geneva, Switzerland;5. Biostatistics Unit, Department of Public Health, Faculty of Medicine & Biomedical Sciences, University of Yaounde I, Cameroon;6. Department of Pharmacology Drugs and Laboratory, Ministry of Public Health, Cameroon;g Department of Ambulatory Care and Community Medicine–Infectious Disease Service, University Hospital, Lausanne, Switzerland |
| |
Abstract: | BackgroundTo ensure vaccines safety, given the weaknesses of the national pharmacovigilance system in Cameroon, there is a need to identify effective interventions that can contribute to improving AEFI reporting.ObjectiveTo assess the effect of: (i) sending weekly SMS, or (ii) weekly supervisory visits on AEFI reporting rate during a meningitis immunization campaign conducted in Cameroon in 2012 using the meningitis A conjugate vaccine (MenAfriVac™).MethodsHealth facilities that met the inclusion criteria were randomly assigned to receive: (i) a weekly standardized SMS, (ii) a weekly standardized supervisory visits or (iii) no intervention. The primary outcome was the reported AEFI incidence rate from week 5 to 8 after the immunization campaign. Poisson regression model was used to estimate the effect of interventions after adjusting for health region, type of health facility, type and position of health workers as well as the cumulative number of AEFI reported from weeks 1 to 4.ResultsA total of 348 (77.2%) of 451 health facility were included, and 116 assigned to each of three groups. The incidence rate of reported AEFI per 100 health facility per week was 20.0 (15.9–24.1) in the SMS group, 40.2 (34.4–46.0) in supervision group and 13.6 (10.1–16.9) in the control group. Supervision led to a significant increase of AEFI reporting rate compared to SMS [adjusted RR = 2.1 (1.6–2.7); p < 0.001] and control [RR = 2.8(2.1–3.7); p < 0.001)] groups. The effect of SMS led to some increase in AEFI reporting rate compared to the control group, but the difference was not statistically significant [RR = 1.4(0.8–1.6); p = 0.07)].ConclusionSupervision was more effective than SMS or routine surveillance in improving AEFI reporting rate. It should be part of any AEFI surveillance system. SMS could be useful in improving AEFI reporting rates but strategies need to be found to improve its effectiveness, and thus maximize its benefits. |
| |
Keywords: | SMS supervision AEFI surveillance Immunization campaign Meningitis vaccine MenAfriVac&trade Cameroon |
本文献已被 ScienceDirect 等数据库收录! |
|